Frontiers in Endocrinology (Sep 2021)

MIRAGE Syndrome Caused by a De Novo c.3406G>C (p. Glu1136Gln) Mutation in the SAMD9 Gene Presenting With Neonatal Adrenal Insufficiency and Recurrent Intussusception: A Case Report

  • Xinyi Chin,
  • Aravind Venkatesh Sreedharan,
  • Ene Choo Tan,
  • Ene Choo Tan,
  • Heming Wei,
  • Jyn Ling Kuan,
  • Christopher Wen Wei Ho,
  • Joyce Ching Mei Lam,
  • Teck Wah Ting,
  • Rashida Farhad Vasanwala

DOI
https://doi.org/10.3389/fendo.2021.742495
Journal volume & issue
Vol. 12

Abstract

Read online

IntroductionPrimary adrenal insufficiency (PAI) presenting in the neonatal period can be life threatening and requires early recognition, diagnosis, and management. PAI due to adrenal hypoplasia (syndromic/non-syndromic) is a rare disorder. MIRAGE is a recently described syndrome with PAI and multisystem involvement.Case PresentationA preterm female neonate presenting with PAI and persistent severe thrombocytopenia was diagnosed to have MIRAGE syndrome due to a de novo pathogenic variant c.3406G>C (p. Glu1136Gln) in the SAMD9 gene. In the first year of life, she had recurrent respiratory and gastrointestinal infection causing failure to thrive. At 17 months, she suffered recurrent intussusception requiring treatment with parenteral nutrition and high-dose steroids. Subsequently, she established oral feeds with hydrolysed formula and demonstrated good weight gain.ConclusionIn neonates presenting with PAI and associated multisystem involvement, a thoughtful approach and genetic testing is valuable in discerning an etiological diagnosis. This case of MIRAGE adds to the spectrum of reported cases and is the first to report on recurrent intussusception and its management with high-dose steroids.

Keywords